Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Annelise Capossela/Axios
The U.K. plans to intentionally infect healthy volunteers with the coronavirus in the world's first "human challenge trial," the goal being to enhance understanding of the virus, the Washington Post reports.
Why it matters: The effort is controversial, but the government says the study will help with developing new treatments and vaccines for the virus.
Details: The government-funded effort will, in the first stage, expose up to 90 young adults to the coronavirus "in a safe and controlled environment" to evaluate the amount of virus needed to cause infection.
- The government hopes in later stages to quickly study vaccines and be able to compare them against one another.
What they're saying: Some experts question whether such a study is necessary, given the existence of highly-effective vaccines.
- But others say that new vaccines will continue to be developed, and will need to be tested.
- The human challenge trials could "give ourselves the potential to test new vaccines very quickly, and that’s really the primary purpose of this effort," Robert Read, a professor of infectious diseases at the University of Southampton, told the Post.